M.P. López-Cabrerizo

711 total citations
8 papers, 577 citations indexed

About

M.P. López-Cabrerizo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, M.P. López-Cabrerizo has authored 8 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in M.P. López-Cabrerizo's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (4 papers) and Genetic factors in colorectal cancer (3 papers). M.P. López-Cabrerizo is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (4 papers) and Genetic factors in colorectal cancer (3 papers). M.P. López-Cabrerizo collaborates with scholars based in Spain. M.P. López-Cabrerizo's co-authors include Rafael Rosell, J.L. González-Larriba, Bartomeu Massutí, P. Lianes, Felipe Cardenal, Vicente Alberola, Binh Nguyen, Á. Artal, Alfredo Carrato and M. Lomas and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and International Journal of Cancer.

In The Last Decade

M.P. López-Cabrerizo

8 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.P. López-Cabrerizo Spain 7 414 404 144 105 72 8 577
Laura Capelli Italy 12 402 1.0× 346 0.9× 153 1.1× 189 1.8× 90 1.3× 32 613
B. E. Johnson United States 12 388 0.9× 359 0.9× 209 1.5× 101 1.0× 36 0.5× 17 534
Johann Raats South Africa 9 280 0.7× 367 0.9× 188 1.3× 83 0.8× 101 1.4× 15 569
C. Ligorio Italy 5 337 0.8× 401 1.0× 139 1.0× 72 0.7× 108 1.5× 6 550
R. Metzger United States 4 234 0.6× 360 0.9× 300 2.1× 106 1.0× 114 1.6× 4 612
Antonella Flacco Italy 9 482 1.2× 381 0.9× 269 1.9× 179 1.7× 67 0.9× 13 623
KS Albain United States 8 427 1.0× 488 1.2× 111 0.8× 107 1.0× 39 0.5× 18 607
M. Lomas Spain 7 364 0.9× 419 1.0× 94 0.7× 52 0.5× 22 0.3× 23 518
Athina Agelidou Greece 14 580 1.4× 629 1.6× 146 1.0× 78 0.7× 35 0.5× 31 756
H. Doubre France 12 524 1.3× 372 0.9× 113 0.8× 81 0.8× 62 0.9× 33 629

Countries citing papers authored by M.P. López-Cabrerizo

Since Specialization
Citations

This map shows the geographic impact of M.P. López-Cabrerizo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.P. López-Cabrerizo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.P. López-Cabrerizo more than expected).

Fields of papers citing papers by M.P. López-Cabrerizo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.P. López-Cabrerizo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.P. López-Cabrerizo. The network helps show where M.P. López-Cabrerizo may publish in the future.

Co-authorship network of co-authors of M.P. López-Cabrerizo

This figure shows the co-authorship network connecting the top 25 collaborators of M.P. López-Cabrerizo. A scholar is included among the top collaborators of M.P. López-Cabrerizo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.P. López-Cabrerizo. M.P. López-Cabrerizo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Cardenal, Felipe, M.P. López-Cabrerizo, Antonio Antón, et al.. (1999). Randomized Phase III Study of Gemcitabine-Cisplatin Versus Etoposide-Cisplatin in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 17(1). 12–12. 389 indexed citations
2.
Sánchez‐Céspedes, Montse, Mariano Monzó, Rafael Rosell, et al.. (1998). Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients. Annals of Oncology. 9(1). 113–116. 74 indexed citations
3.
Felip, Enriqueta, Bartomeu Massutí, Carlos Camps, et al.. (1998). Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trials.. PubMed. 4(11). 2723–8. 12 indexed citations
4.
Rosell, Rafael, Àlex Pifarré, Mariano Monzó, et al.. (1997). Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errors. International Journal of Cancer. 74(3). 330–334. 50 indexed citations
5.
Rosell, Rafael, M.P. López-Cabrerizo, & Julio Astudillo. (1997). Preoperative chemotherapy for stage MIA non-small cell lung cancer. Current Opinion in Oncology. 9(2). 149–155. 16 indexed citations
6.
Sánchez‐Céspedes, Montse, R. Rosell, Àlex Pifarré, et al.. (1997). Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.. PubMed. 3(7). 1229–35. 23 indexed citations
7.
Rosell, Rafael, et al.. (1997). A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancer.. PubMed. 24(4 Suppl 12). S12–56. 5 indexed citations
8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Capelli Breakdown of academic impact, for papers by B. E. Johnson Breakdown of academic impact, for papers by Johann Raats Breakdown of academic impact, for papers by C. Ligorio Breakdown of academic impact, for papers by R. Metzger Breakdown of academic impact, for papers by Antonella Flacco Breakdown of academic impact, for papers by KS Albain Breakdown of academic impact, for papers by M. Lomas Breakdown of academic impact, for papers by Athina Agelidou Breakdown of academic impact, for papers by H. Doubre
Rankless by CCL
2026